BioLight’s New Investment in Belkin Laser Ltd., a medical device company which develops an innovative one-second Glaucoma laser treatment

Tel Aviv (December 22, 2019) – BioLight is pleased to announce that today, it has signed a binding agreement for its investment in Belkin Laser Ltd. (the “Agreement” and “Belkin Laser”). According to the Agreement, BioLight shall invest approx. USD 1M in consideration for the issuance of Preferred B shares in Belkin Laser, out of an investment round (including loans’ conversions), of up to USD 5M with other investors

Link to the complete article

Link to Newsroom

Comments are closed.